Projects per year
Personal profile
Education/Academic qualification
3.1 Basic medicine, Corresponding Member, Latvian Council of Science, Latvian Council of Science
11 Dec 2024 → …
Award Date: 21 Nov 2024
3.2 Clinical medicine, Expert, Latvian Council of Science
8 May 2025 → 7 May 2028
3.2 Clinical medicine, Expert, Latvian Council of Science
7 Jul 2022 → 6 Jul 2025
3.2 Clinical medicine, Expert, Latvian Council of Science
17 Oct 2019 → 16 Oct 2022
3.1 Basic medicine, Expert, Latvian Council of Science
21 Oct 2016 → 20 Oct 2019
Field of Science
- 3.2 Clinical medicine
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Prospective study of trace elements in breast cancer risk and treatment response
Irmejs, A. (Project leader), Vanadziņš, I. (Leading expert), Paegle, D. I. (Expert), Lapiņa, D. (Expert), Šķesters, A. (Expert), Strēle, I. (Expert), Ilsuma, L. (Assistant (student)) & Rotberga, L. (Assistant (student))
1/01/26 → 31/12/28
Project: Fundamental and Applied Research Programme
-
JA PCM: Joint Action Personalised Cancer Medicine
Irmejs, A. (Partner's coordinator), Čakstiņa-Dzērve, I. (Work package leader) & De Nicolo, A. (Work package leader)
1/11/25 → 31/10/29
Project: EU Programmes › Other
-
PREDI-LYNCH: Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
Dominguez-Valentin, M. (Project leader), Irmejs, A. (Partner's coordinator), Poikāne, E. (Expert) & Daneberga, Z. (Leading expert)
1/09/25 → 31/08/31
Project: EU Programmes › Horizon Europe
-
Development of screening algorithm for high breast cancer risk by analysis of spectrum of predisposing mutations and their phenotypic manifestations
Irmejs, A. (Project leader), Daneberga, Z. (Leading expert), Maksimenko, J. (Leading expert), Loža, P. (Expert (PhD student)), Berga-Švītiņa, E. (Expert (PhD student)), Kuzņecova, E. (Expert (PhD student)), Subatniece, S. (Expert), Liepiņa, E. E. (Participant), Čerņeikina, A. (Participant) & Gržeļahovska, A. (Participant)
7/02/22 → 31/12/29
Project: Contract research › R&D project
-
Patient reported outcome measures in breast cancer patients: a pilot study
Poplavska, E. (Project leader), Irmejs, A. (Leading expert), Spriņģe, L. (Leading expert), Trups-Kalne, I. (Leading expert), Maksimenko, J. (Expert), Nesaule, L. (Assistant (student)), Siltumēna, S. (Assistant (student)), Tihomirova, Ļ. (Participant), Šteina, V. (Participant), Kokarēviča, A. (Participant), Muižniece, Z. (Participant), Pacukēviča Štope, V. (Participant) & Rotberga, L. R. (Participant)
1/04/24 → 31/03/26
Project: Consolidation grants
-
Increasing uptake of risk-reducing bilateral mastectomy in Latvia: Trends from a national BRCA carrier cohort
Loža, P., Irmejs, A., Gardovskis, J., Daneberga, Z. & Maksimenko, J., Mar 2026, In: European Journal of Cancer. 237, Suppl.1, p. 140-141Research output: Contribution to journal › Meeting Abstract
-
The Impact of Oophorectomy on Breast Cancer Survival in Patient with a BRCA1 Mutation
Narod, S., Lubinski, J., Wong, S., Soukupova, J., Bernstein, R., Fruscio, R., Plichta, J., Lee, M., Irmejs, A., Evans, G., Ngeow, J., Tung, N., Metcalfe, K. & Sun, P., 17 Feb 2026, In: Clinical Cancer Research. 32, Suppl.4, PS3-01-29.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Implementing mainstream germline genetic testing in breast cancer across Europe
Pérez-Ballestero, E., Shire, S. A., Krajc, M., Irmejs, A., Foretová, L., Frank, S., Kahre, T., van Overeem Hansen, T., Koppert, L., Burgemeister, A. L., Tischkowitz, M., Balmaña, J., Bajalica-Lagercrantz, S. (Corresponding Author) & ERN GENTURIS, 3 Feb 2026, In: BJC reports. 4, 1, 3.Research output: Contribution to journal › Review article › peer-review
Open AccessFile -
The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer
Loža, P. (Corresponding Author), Irmejs, A., Daneberga, Z., Maksimenko, J., Trofimovičs, G., Subatniece, S., Gronwald, J., Lubinski, J. & Gardovskis, J., Dec 2025, In: BMC Cancer. 25, 1, 1769.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
BRCA1/2 population genetic screening: challenges and benefits
Daneberga, Z., Irmejs, A., Kļujeva, A., Kriķe, N., Liepiņa, E. E., Vīksne, K., Ciematnieks, R., Lakuča, U., Ķiploka, K., Hoberg-Vetti, H., Bjorvatn, C., Kononova, I., Syundyukov, E., Danovska, I., Kalcenaua, A., Mednis, M., Pildegovica, E., Lindenberga, I., Miklaševičs, E. & Gardovskis, J., Nov 2025, In: European Journal of Human Genetics. 33, Suppl.1, p. 556-556 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Datasets
-
Development of Genetic Testing Strategies for Hereditary Breast and Ovarian Cancer Risk Prediction by Analysis of Spectrum of Predisposing Mutations and Their Phenotypic Manifestations: Clinical Data
Irmejs, A. (Creator), Loža, P. (Creator), Maksimenko, J. (Creator), Daneberga, Z. (Creator), Liepiņa, E. E. (Creator) & Čerņeikina, A. (Creator), Rīga Stradiņš University Institutional Repository Dataverse, 10 Apr 2026
DOI: 10.48510/fk2/ajiivr, https://doi.org/10.48510/FK2/AJIIVR
Dataset
-
Development of Genetic Testing Strategies for Hereditary Breast and Ovarian Cancer Risk Prediction by Analysis of Spectrum of Predisposing Mutations and Their Phenotypic Manifestations: Genetic Data
Irmejs, A. (Creator), Loža, P. (Creator), Maksimenko, J. (Creator), Daneberga, Z. (Creator), Liepiņa, E. E. (Creator) & Čerņeikina, A. (Creator), Rīga Stradiņš University Institutional Repository Dataverse, 9 Apr 2026
DOI: 10.48510/fk2/b4v921
Dataset
Activities
-
Breast Cancer Genetics Consortia Meeting
Irmejs, A. (Participant)
17 Jun 2026 → 19 Jun 2026Activity: Participating in or organising an event types › Participating in a conference, workshop, ...
-
Germline variant spectrum in Latvian ovarian cancer patients: from BRCA1 founder screening to multi-gene panel analysis
Čerņeikina, A. (Speaker), Loža, P. (Co-author), Maksimenko, J. (Co-author), Prušakeviča, A. (Co-author), Liepiņa, E. E. (Co-author), Gržeļahovska, A. (Co-author), Daneberga, Z. (Co-author) & Irmejs, A. (Speaker)
13 Jun 2026Activity: Talk or presentation types › Poster presentation
-
Starppaaudžu ģenētiskie riski onkoloģijā
Irmejs, A. (Speaker)
5 Jun 2026Activity: Talk or presentation types › Oral presentation
-
EUnetCCC: European Network of Comprehensive Cancer Centres CORE GROUP MEETING 28-29 MAY, HELSINKI
Irmejs, A. (Participant)
28 May 2026 → 29 May 2026Activity: Participating in or organising an event types › Participating in a conference, workshop, ...
-
Prevention, diagnostics and treatment of hereditary cancer – a clear example of personalized medicine in clinical practice
Irmejs, A. (Speaker), Daneberga, Z. (Speaker) & Loža, P. (Speaker)
28 Apr 2026Activity: Talk or presentation types › Oral presentation
Press/Media
-
Tā nav fantazēšana – reāli pētījumi, kas pavisam drīz būtiski var uzlabot smagu slimību ārstēšanu
Irmejs, A., Čakstiņa-Dzērve, I., Prustijs, B. K., Nora-Krūkle, Z., Rācenis, K. & Edelmers, E.
9/07/26
1 Media contribution
Press/Media
-
Pussimts sieviešu Stradiņos izvēlējušās Džolijas ceļu. Kā sevi pasargāt no pārmantotā vēža riska
30/06/26
1 item of Media coverage
Press/Media
-
-
Ģimenē bijis krūts vai olnīcu vēzis? RSU pētnieku ieteikumi sievietēm ar iespējamu pārmantotas slimības risku
10/09/25
1 Media contribution
Press/Media
-